Less frequently, loss-of-function mutation of AXIN1, AXIN2, or APC is found in 3.2%, 0.4%, and 0.2% of HCCs respectively, evidently contrasting with the situation in colorectal cancer, where up to 80% of cancers display mutated APC [36, 37]. This evidence concerns the gene AXIN2 and cancer.